Literature DB >> 15501030

In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones.

Rosanna Maccari1, Rosaria Ottanà, Bruno Bottari, Enrico Rotondo, Maria Gabriella Vigorita.   

Abstract

The in vitro antimycobacterial activity of cobalt(II) and copper(II) complexes of some fluorinated isonicotinoylhydrazones was evaluated in a TB-infected macrophage model; all metalcomplexes exhibited excellent activity against Mycobacterium tuberculosis Erdman growing within macrophages, at concentrations much lower than in culture media. Moreover complexes 1b and 2a displayed EC(99) values lower than that of the parent-drug, isoniazid. In addition, all tested metalchelates significantly inhibited the growth of single-drug-resistant M. tuberculosis strains; complexes 1a and 2a also possessed moderate activity against Mycobacterium avium complex.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501030     DOI: 10.1016/j.bmcl.2004.09.052

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  ON donor tethered copper (II) and vanadium (V) complexes as efficacious anti-TB and anti-fungal agents with spectroscopic approached HSA interactions.

Authors:  Anamika Sinha; Riya Chaudhary; Dinesh S Reddy; Manasa Kongot; Mahantesh M Kurjogi; Amit Kumar
Journal:  Heliyon       Date:  2022-08-11

2.  In Vitro Activity of Copper(II) Complexes, Loaded or Unloaded into a Nanostructured Lipid System, against Mycobacterium tuberculosis.

Authors:  Patricia B da Silva; Paula C de Souza; Giovana Maria Fioramonti Calixto; Erica de O Lopes; Regina C G Frem; Adelino V G Netto; Antonio E Mauro; Fernando R Pavan; Marlus Chorilli
Journal:  Int J Mol Sci       Date:  2016-05-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.